Raymond James Financial Services Advisors, Inc. Jazz Pharmaceuticals PLC Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 4,417 shares of JAZZ stock, worth $499,121. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,417
Previous 5,391
18.07%
Holding current value
$499,121
Previous $575,000
14.43%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding JAZZ
# of Institutions
601Shares Held
60.5MCall Options Held
424KPut Options Held
190K-
Black Rock Inc. New York, NY6.15MShares$694 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.02MShares$680 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.47MShares$279 Million0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.33MShares$263 Million0.07% of portfolio
-
State Street Corp Boston, MA1.97MShares$222 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.08B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...